Johnson Danielle P, Chandrasekharan Mahesh B, Dutreix Marie, Bhaskara Srividya
Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.
Institut Curie, CNRS, INSERM, University Centre, 91405 Orsay, France.
Cancers (Basel). 2021 Jan 20;13(3):381. doi: 10.3390/cancers13030381.
Aberrant DNA repair pathways that underlie developmental diseases and cancers are potential targets for therapeutic intervention. Targeting DNA repair signal effectors, modulators and checkpoint proteins, and utilizing the synthetic lethality phenomena has led to seminal discoveries. Efforts to efficiently translate the basic findings to the clinic are currently underway. Chromatin modulation is an integral part of DNA repair cascades and an emerging field of investigation. Here, we discuss some of the key advancements made in DNA repair-based therapeutics and what is known regarding crosstalk between chromatin and repair pathways during various cellular processes, with an emphasis on cancer.
构成发育性疾病和癌症基础的异常DNA修复途径是治疗干预的潜在靶点。靶向DNA修复信号效应器、调节剂和检查点蛋白,并利用合成致死现象已带来了重大发现。目前正在努力将这些基础研究成果有效地转化到临床应用中。染色质调节是DNA修复级联反应的一个组成部分,也是一个新兴的研究领域。在此,我们讨论基于DNA修复的治疗方法取得的一些关键进展,以及在各种细胞过程中,尤其是在癌症中,染色质与修复途径之间的相互作用的相关知识。